Document
type: Class

Academic Article
type: Class

Continuant
type: Class

Entity
type: Class

RDF description of Efficacy and safety of the novel capsid inhibitor lenacapavir to treat multidrug-resistant HIV: week 52 results of a phase 2/3 trial - http://irises.unisr.it/resource/item/155386
rights: termsOfUse
date: 2026-08-24T09:42:47
publisher: Efficacy and safety of the novel capsid inhibitor lenacapavir to treat multidrug-resistant HIV: week 52 results of a phase 2/3 trial
type: Document

Generically Dependent Continuant
type: Class

Article
type: Class

Inglese
type: Language

Information Content Entity
type: Class

441524377
type: Entity
type: BFO_0000020
type: Authorship
type: Relationship
type: Continuant
type: Thing
relates: Efficacy and safety of the novel capsid inhibitor lenacapavir to treat multidrug-resistant HIV: week 52 results of a phase 2/3 trial

Efficacy and safety of the novel capsid inhibitor lenacapavir to treat multidrug-resistant HIV: week 52 results of a phase 2/3 trial
type: Entity
type: Continuant
type: Document
type: Thing
related by: 441524377
language: Inglese
type: Article
type: Academic Article
type: Information Content Entity
type: Generically Dependent Continuant
most specific type: Academic Article